Tag: REDUCE-IT

Inflammation stronger predictor of MACE than cholesterol levels

Presented By
Prof. Paul Ridker, Brigham and Women's Hospital, MA, USA
Trial
Phase 3, PROMINENT, REDUCE-IT, STRENGTH
Conference
ACC 2023
Type
Peer-reviewed article

7 June 2023 09:36

REDUCE-IT: Cardiovascular risk reduction with icosapent ethyl in PAD

Presented By
Dr Deepak Bhatt, Brigham and Women’s Hospital, Boston, USA
Trial
Phase 3, REDUCE-IT
Conference
AHA 2021
Type
Peer-reviewed article

14 January 2022 15:36

STRENGTH trial fails to demonstrate cardioprotective effect of omega-3 fatty acids

Presented By
Dr Steven Nissen, Cleveland Clinic, USA
Trial
STRENGTH, REDUCE-IT
Conference
ACC 2021
Type
Peer-reviewed article

9 July 2021 23:25

Higher serum levels of eicosapentaenoic acid correlate with reduced CV events

Presented By
Dr D. Bhatt, Brigham and Women's Hospital, USA
Trial
REDUCE-IT EPA analysis
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 13:44

Convincing evidence of the role of icosapent in reducing subsequent CV events

Presented By
Prof. Deepak Bhatt, Brigham and Women’s Hospital, USA
Trial
REDUCE-IT
Conference
ACC 2019
Type
Peer-reviewed article

6 June 2019 13:57
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com